RxDoctor Payments Data

Kenneth Dodge, MD

Family Medicine · Franklin, TNNPI 1417951302

Payments from drug & device makers

$5,548in general payments, 2019–2025

Across 350 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Boehringer Ingelheim$813
  • Amgen$541
  • AbbVie$430
  • AstraZeneca$302
  • GSK$211
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$5,43198%
  • Education$1162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,548 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$171,636
Medicare patients
360
Services billed
3,427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban142$102,119
OzempicSemaglutide84$91,399
TrulicityDulaglutide42$73,552
AustedoDeutetrabenazine11$64,401
JardianceEmpagliflozin57$61,250
JanuviaSitagliptin Phosphate45$51,122
MounjaroTirzepatide29$31,385
XareltoRivaroxaban43$30,658
LinzessLinaclotide36$30,407
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$27,495
MyrbetriqMirabegron17$13,166
GemtesaVibegron24$12,874
Memantine Hcl148$10,636
Atorvastatin Calcium517$7,088
TradjentaLinagliptin17$7,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$198$104,93771 claims
PfizerEliquis$131$102,119142 claims
Novo NordiskOzempic$1,184$91,39984 claims
Boehringer IngelheimJardiance, Tradjenta$813$68,28574 claims
MerckJanuvia$140$51,12245 claims
AbbVieLinzess, Synthroid$430$33,25194 claims
Johnson & JohnsonXarelto$191$30,65843 claims
GSKTrelegy Ellipta$211$27,49530 claims
Astellas Pharma US IncMyrbetriq$133$13,16617 claims
Sumitomo Pharma America, Inc.Gemtesa$15$12,87424 claims
Sanofi-aventis U.S. LLCLantus$132$5,79354 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →